EN
DE 
NL 
FR 
ES 
IT 
CS 
PL CONDITION
Preliminary studies on cannabis for migraine are encouraging and some people report relief, but rigorous controlled trials are still lacking.
What the research says
Observational studies and surveys suggest cannabis may reduce migraine frequency or severity for some people, and there is a plausible link through the endocannabinoid system. However, well-controlled clinical trials are scarce, so the evidence is best described as emerging rather than established.
A note on rebound
As with conventional acute migraine medicines, there is a theoretical risk that frequent use could contribute to medication-overuse (rebound) headaches, though this is not well characterised for cannabis.
At a glance
What to be careful about
Migraine has effective modern treatments. Cannabis is not a proven migraine therapy, and frequent headaches should be assessed by a clinician.
Continue exploring
Neurological and pharmacological studies in Cannabis and Cannabinoid Research (Russo, 2016, PMID 28861491), Pharmacotherapy (Rhyne et al., 2016, PMID 26749285), and The Journal of Pain (Cuttler et al., 2020, PMID 31760109) investigate how cannabinoids interact with the trigeminovascular system, calcitonin gene-related peptide (CGRP) release, and cerebrospinal anandamide levels. While retrospective cohorts report reductions in monthly migraine frequency and acute pain severity, clinicians monitor carefully for medication-overuse (rebound) headache with frequent high-THC use.
Frequently Asked Questions
How does the endocannabinoid system relate to migraine pathophysiology?
Cerebrospinal fluid studies cited in Clinical Endocannabinoid Deficiency research show lower baseline anandamide (AEA) levels in chronic migraine patients, which may reduce inhibitory CB1 control over trigeminovascular pain and CGRP release.
What did observational human studies find on migraine frequency?
In the retrospective cohort by Rhyne et al. (2016, PMID 26749285), patients using medical cannabis reported a decrease in mean monthly migraine frequency from 10.4 to 4.6 headaches per month.
Can frequent high-THC use trigger medication-overuse (rebound) headache?
Yes. Longitudinal headache research warns that frequent high-THC exposure can increase the risk of medication-overuse headache and tolerance over time.
Sources & Neurological References
- Russo, E. B. (2016). "Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes." Cannabis and Cannabinoid Research, 1(1), 154-165. PubMed PMID 28861491.
- Rhyne, D. N., Anderson, S. L., Gedde, M., & Borgelt, L. M. (2016). "Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population." Pharmacotherapy, 36(5), 505-510. PubMed PMID 26749285.
- Cuttler, C., Spradlin, A., Cleveland, M. J., & Craft, R. M. (2020). "Short- and Long-Term Effects of Cannabis on Headache and Migraine." The Journal of Pain, 21(5-6), 722-730. PubMed PMID 31760109.
English